Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed N.V. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

May 12, 2015

Affimed to Present at the UBS Global Healthcare Conference – New York

May 12, 2015

Affimed N.V. Announces Pricing of Public Offering of Common Stock

May 6, 2015

Affimed N.V. Announces Proposed Public Offering of Common Stock

May 4, 2015

Affimed Announces Financial Results for Fourth Quarter and Year End 2014

March 25, 2015

Affimed Announces Fourth Quarter and Year End 2014 Financial Results Conference Call

March 18, 2015

Affimed to Present at the 27th Annual ROTH Conference

March 3, 2015

Affimed to Present at the BIO CEO & Investor Conference and at the Leerink Partners Global Healthcare Conference

February 3, 2015

Affimed Appoints Dr. Martin Treder as Chief Scientific Officer

January 20, 2015

Affimed Receives EUR 2.4 million ($3 million) Research Grant from German Government to Fund Trispecific Abs

January 7, 2015

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25

Events

All
Scientific
Investors

There are no events planned at the moment.

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2022 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact